Verition Fund Management’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-915,000
Closed -$36.1M – 2446
2026
Q2
$36.1M Buy
915,000
+59,430
+7% +$2.39M 0.18% 108
2026
Q1
$38.1M Buy
855,570
+105,570
+14% +$4.66M 0.25% 61
2025
Q4
$31.5M Buy
+750,000
New +$31.7M 0.12% 112

Other funds holding MDLN

Verition Fund Management's MDLN Position: Q3 2026 in Review

Verition Fund Management sold out of Medline (MDLN) in Q3 2026, closing a stake of 915,000 shares — an estimated $36.1M sold.

Verition Fund Management first reported a position in MDLN in Q4 2025 and held it in 3 quarters. The position peaked at $38.1M in Q1 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Verition Fund Management reported no remaining Medline position as of Q3 2026 after selling out during the quarter.
  • Verition Fund Management sold 915,000 Medline shares in Q3 2026, an estimated $36.1M.
  • Verition Fund Management first reported a position in Medline in Q4 2025 and held it in 3 quarters.
  • Verition Fund Management's Medline position peaked at $38.1M in Q1 2026.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.